OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Therapeutic Advances and Unmet Challenges in mCRPC

home / peer-exchange / treating-mcrpc
Introduction: Therapeutic Advances in mCRPC

EP. 1: Introduction: Therapeutic Advances in mCRPC

May 28th 2014
AUA Castration-Resistant Prostate Cancer Guidelines

EP. 2: AUA Castration-Resistant Prostate Cancer Guidelines

May 28th 2014
NCCN and AUA Prostate Cancer Guidelines

EP. 3: NCCN and AUA Prostate Cancer Guidelines

May 28th 2014
Role of Imaging in M0 CRPC

EP. 4: Role of Imaging in M0 CRPC

May 28th 2014
Preventing SREs in Prostate Cancer

EP. 5: Preventing SREs in Prostate Cancer

May 28th 2014
Antiandrogen Monotherapy for mCRPC

EP. 6: Antiandrogen Monotherapy for mCRPC

May 28th 2014
Prognostic Biomarker Tests for Prostate Cancer

EP. 7: Prognostic Biomarker Tests for Prostate Cancer

May 28th 2014
Biopsy, Biomarkers, and Imaging in Prostate Cancer

EP. 8: Biopsy, Biomarkers, and Imaging in Prostate Cancer

May 28th 2014
Biomarkers in the Management of Prostate Cancer

EP. 9: Biomarkers in the Management of Prostate Cancer

May 28th 2014
Evolution of Treatment for mCRPC

EP. 10: Evolution of Treatment for mCRPC

May 28th 2014
Multidisciplinary Approach to mCRPC Treatment

EP. 11: Multidisciplinary Approach to mCRPC Treatment

May 28th 2014
Treating Symptomatic Bone Metastatic CRPC

EP. 12: Treating Symptomatic Bone Metastatic CRPC

May 28th 2014
Oral Hormonal Agents for mCRPC

EP. 13: Oral Hormonal Agents for mCRPC

May 28th 2014
Treating mCRPC with Newer Hormonal Agents

EP. 14: Treating mCRPC with Newer Hormonal Agents

May 28th 2014
Antiandrogens-Differences and Sequencing

EP. 15: Antiandrogens-Differences and Sequencing

May 28th 2014
Radium-223: Treatment Considerations

EP. 16: Radium-223: Treatment Considerations

May 28th 2014
Sipuleucel-T in Castration-Resistant Prostate Cancer

EP. 17: Sipuleucel-T in Castration-Resistant Prostate Cancer

May 28th 2014
Treatment Advances in Metastatic CRPC

EP. 18: Treatment Advances in Metastatic CRPC

May 28th 2014
SREs, Risk Stratification, and Agents in Development

EP. 19: SREs, Risk Stratification, and Agents in Development

May 28th 2014
Role of Nurses and Other Care Providers

EP. 20: Role of Nurses and Other Care Providers

May 28th 2014
Role of Urologists in Advanced Prostate Cancer Clinics

EP. 21: Role of Urologists in Advanced Prostate Cancer Clinics

May 28th 2014

Latest Conference Coverage

Ribociclib/Endocrine Therapy Yields Similar pCRs Compared With Chemotherapy in HR+ Early Breast Cancer

Emiltatug Ledadotin Shows Early Clinical Activity and Safety in Advanced/Metastatic TNBC

Puxitatug Samrotecan Yields Responses With Manageable Safety in Pretreated HR+/HER2– Advanced Breast Cancer

Adjuvant Pertuzumab Plus Trastuzumab and Chemotherapy Leads to OS Benefit in Early-Stage HER2+ Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact